Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2025)

Serina Therapeutics (SER) posted Exchange Rate Effect of -$12000.0 for Q4 2025, down 500.0% sequentially from -$2000.0 in Q4 2020.

Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2025) Analysis & Trends

Serina Therapeutics has reported Exchange Rate Effect for 4 years, with the latest figure at -$12000.0 in Q4 2025.

Quarterly Exchange Rate Effect changed N/A year-over-year to -$12000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$16000.0 (down 900.0% YoY) and the FY2025 annual result came in at -$14000.0, changed N/A from the prior year.
Exchange Rate Effect slipped to -$12000.0 in Q4 2025 per SER's latest filing, from -$2000.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at -$12000.0 in Q4 2025 and troughed at -$12000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	139.61 Bn	131.75 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	86.70 Bn	78.71 Bn	3.93 Bn	-300,000.00
3	Argenx Se	65.28 Bn	60.09 Bn	1.37 Bn	-
4	Moderna	59.14 Bn	54.00 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	42.13 Bn	37.03 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	31.83 Bn	28.52 Bn	992.69 Mn	-2.45 Mn
7	BioNTech SE	28.07 Bn	9.68 Bn	668.28 Mn	1.63 Mn
8	Insmed	27.54 Bn	26.38 Bn	358.27 Mn	-287,000.00
9	Royalty Pharma	27.31 Bn	26.47 Bn	-	-
10	Serina Therapeutics	43.42 Mn	20.40 Mn	-	-

Download Data